文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

壳聚糖非微粒疫苗递送系统

Chitosan non-particulate vaccine delivery systems.

作者信息

Masimov Rasim, Wasan Ellen K

机构信息

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.

出版信息

J Pharm Pharm Sci. 2024 Jul 24;27:12921. doi: 10.3389/jpps.2024.12921. eCollection 2024.


DOI:10.3389/jpps.2024.12921
PMID:39114808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11303186/
Abstract

Chitosan is an extensively used polymer for drug delivery applications in particulate and non-particulate carriers. Chitosan-based particulate, nano-, and microparticle, carriers have been the most extensively studied for the delivery of therapeutics and vaccines. However, chitosan has also been used in vaccine applications for its adjuvant properties in various hydrogels or as a carrier coating material. The focus of this review will be on the usage of chitosan as a vaccine adjuvant based on its intrinsic immunogenicity; the various forms of chitosan-based non-particulate delivery systems such as thermosensitive hydrogels, microneedles, and conjugates; and the advantages of its role as a coating material for vaccine carriers.

摘要

壳聚糖是一种广泛应用于药物递送的聚合物,可用于颗粒和非颗粒载体。基于壳聚糖的颗粒、纳米和微粒载体在治疗药物和疫苗递送方面得到了最为广泛的研究。然而,壳聚糖还因其在各种水凝胶中的佐剂特性或作为载体包衣材料而被用于疫苗应用。本综述的重点将是基于壳聚糖固有的免疫原性,探讨其作为疫苗佐剂的用途;基于壳聚糖的各种非颗粒递送系统,如热敏水凝胶、微针和结合物;以及其作为疫苗载体包衣材料的优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/a39b52d64f63/jpps-27-12921-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/419aa157fd4c/jpps-27-12921-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/497037a1f8f3/jpps-27-12921-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/3f78e8a5dace/jpps-27-12921-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/d5e682197329/jpps-27-12921-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/8c19c0106da8/jpps-27-12921-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/e4f25f2ad5f2/jpps-27-12921-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/9767498dc0a9/jpps-27-12921-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/a39b52d64f63/jpps-27-12921-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/419aa157fd4c/jpps-27-12921-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/497037a1f8f3/jpps-27-12921-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/3f78e8a5dace/jpps-27-12921-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/d5e682197329/jpps-27-12921-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/8c19c0106da8/jpps-27-12921-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/e4f25f2ad5f2/jpps-27-12921-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/9767498dc0a9/jpps-27-12921-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f012/11303186/a39b52d64f63/jpps-27-12921-g008.jpg

相似文献

[1]
Chitosan non-particulate vaccine delivery systems.

J Pharm Pharm Sci. 2024-7-24

[2]
Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.

J Pharm Pharmacol. 2008-12

[3]
Chemical Modification of Chitosan for Efficient Vaccine Delivery.

Molecules. 2018-1-25

[4]
Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.

J Liposome Res. 2011-12-22

[5]
Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.

Curr Drug Deliv. 2017

[6]
Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases.

Int J Biol Macromol. 2017-10-18

[7]
Novel application of trimethyl chitosan as an adjuvant in vaccine delivery.

Int J Nanomedicine. 2018-11-23

[8]
Chitosan-based hydrogels for controlled, localized drug delivery.

Adv Drug Deliv Rev. 2009-9-30

[9]
Controlled Liposome Delivery from Chitosan-Based Thermosensitive Hydrogel for Regenerative Medicine.

Int J Mol Sci. 2022-1-14

[10]
In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery.

Eur J Pharm Sci. 2010-7-13

本文引用的文献

[1]
Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity.

Vaccines (Basel). 2023-7-31

[2]
Application of microneedles combined with dendritic cell-targeted nanovaccine delivery system in percutaneous immunotherapy for triple-negative breast cancer.

Nanotechnology. 2023-9-5

[3]
Oral delivery of a Streptococcus agalactiae vaccine to Nile tilapia (Oreochromis niloticus) using a novel cationic-based nanoemulsion containing bile salts.

Fish Shellfish Immunol. 2023-8

[4]
A synthetic Tn-BSA conjugate vaccine bearing chitotriose as built-in adjuvant.

Carbohydr Res. 2023-8

[5]
A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against .

Front Immunol. 2023

[6]
Design and evaluation of chitosan-amino acid thermosensitive hydrogel.

Mar Life Sci Technol. 2021-9-16

[7]
Immunological evaluation of a recombinant vaccine delivered with an analogous hyaluronic acid chitosan nanoparticle-hydrogel against Toxoplasma gondii in mice.

Microb Pathog. 2023-6

[8]
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies.

Nat Commun. 2023-3-30

[9]
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines.

J Control Release. 2023-1

[10]
Nucleic Acid Vaccines against SARS-CoV-2.

Vaccines (Basel). 2022-10-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索